A two-year liver health project is underway across the Humber region, aiming to enhance patient care, reduce emergency ...

Cardiovascular disease (CVD) is the most common cause of death in NAFLD patients. Liver biopsy and noninvasive markers should be used to stage and grade nonalcoholic steatohepatitis (NASH ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient.

“Detecting cancer early results in less aggressive treatment and a higher chance of recovery. Some screening tests can detect ...

My brother was diagnosed with hepatitis C two years ago. Our family hopes to destigmatize the condition and encourage others ...